miocamycin has been researched along with Peritoneal Carcinomatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashiguchi, K; Hiraki, M; Kitajima, Y; Koga, Y; Miyazaki, K; Nakamura, J; Noshiro, H; Tanaka, T | 1 |
1 other study(ies) available for miocamycin and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Aberrant gene methylation is a biomarker for the detection of cancer cells in peritoneal wash samples from advanced gastric cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Biomarkers, Tumor; Cell Cycle Proteins; Cytochrome P-450 CYP1B1; DNA Methylation; DNA, Neoplasm; Feasibility Studies; Female; Gastric Mucosa; Humans; Male; Membrane Proteins; Middle Aged; Miocamycin; Neoplasm Micrometastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Lavage; Peritoneal Neoplasms; Poly-ADP-Ribose Binding Proteins; Polymerase Chain Reaction; Prognosis; Proto-Oncogene Proteins; Stomach Neoplasms; Survival Rate; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases | 2011 |